From: Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
Characteristic | HR | 95% CI | P value |
---|---|---|---|
Sex | |||
Male | Reference | ||
Female | 0.72 | 0.44–1.18 | 0.195 |
Ethnicity | |||
Caucasian | Reference | ||
African–American | 2.88 | 1.55–5.36 | 0.001 |
Others | 1.02 | 0.54–1.94 | 0.947 |
Age at diagnosis (years) | |||
0–1 | Reference | ||
2–4 | 1.64 | 1.03–2.61 | 0.038 |
5–18 | 1.06 | 0.41–2.71 | 0.909 |
Year of diagnosis | |||
2004–2007 | Reference | ||
2008–2011 | 0.68 | 0.40–1.16 | 0.155 |
2012–2015 | 0.84 | 0.47–1.48 | 0.540 |
Tumor size | |||
≤ 5 cm | Reference | ||
> 5 cm | 3.81 | 0.92–15.72 | 0.065 |
Unknown | 6.13 | 1.39–27.09 | 0.017 |
Tumor stage | |||
Local | Reference | ||
Regional | 2.04 | 1.10–3.79 | 0.024 |
Distant | 3.42 | 1.87–6.26 | < 0.001 |
Unstaged | 2.49 | 0.77–8.07 | 0.129 |
AFP status | |||
Negative | Reference | ||
Positive | 2.19 | 0.30–16.15 | 0.442 |
Unknown | 3.01 | 0.39–23.18 | 0.291 |